Description

Koninklijke Philips N.V., a prominent global health technology enterprise, conducts its operations across North America and various international markets. The company's business activities are structured into three primary segments: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment division, Philips provides sophisticated diagnostic imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT) scanners, X-ray systems, and spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. This segment also encompasses integrated systems for interventional procedures, ultrasound (echography) devices vital for diagnosis, treatment planning, and guidance in cardiology, general imaging, obstetrics/gynecology, and point-of-care settings, as well as proprietary software to aid diagnostics and interventions, complemented by comprehensive enterprise diagnostic informatics products and services. The Connected Care segment delivers solutions for acute patient management, emergency medical services, and sleep and respiratory care, extending to electronic medical record and various care management platforms. Meanwhile, the Personal Health division markets consumer products such as electric toothbrushes, brush heads, interdental cleaning, and teeth whitening items. It further offers infant feeding and digital parenting technologies, along with male grooming and beauty appliances. Philips has forged key collaborations, including a strategic alliance with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to healthcare providers globally, and a strategic partnership with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the enterprise rebranded from Koninklijke Philips Electronics N.V. to its current name, Koninklijke Philips N.V., in May 2013.